Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005759 | mitochondrial matrix | 5 | 11 |
GO:0031974 | membrane-enclosed lumen | 2 | 11 |
GO:0043233 | organelle lumen | 3 | 11 |
GO:0070013 | intracellular organelle lumen | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9B607
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 11 |
GO:0006974 | DNA damage response | 4 | 11 |
GO:0006996 | organelle organization | 4 | 11 |
GO:0007005 | mitochondrion organization | 5 | 11 |
GO:0007006 | mitochondrial membrane organization | 5 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0033554 | cellular response to stress | 3 | 11 |
GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 11 |
GO:0050896 | response to stimulus | 1 | 11 |
GO:0051716 | cellular response to stimulus | 2 | 11 |
GO:0061024 | membrane organization | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0065008 | regulation of biological quality | 2 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0090559 | regulation of membrane permeability | 3 | 11 |
GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death | 5 | 11 |
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.300 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.380 |
CLV_PCSK_FUR_1 | 279 | 283 | PF00082 | 0.451 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.300 |
CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.518 |
CLV_PCSK_KEX2_1 | 281 | 283 | PF00082 | 0.430 |
CLV_PCSK_PC1ET2_1 | 254 | 256 | PF00082 | 0.518 |
CLV_PCSK_PC1ET2_1 | 281 | 283 | PF00082 | 0.407 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.438 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 251 | 255 | PF00082 | 0.377 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.634 |
DEG_APCC_DBOX_1 | 73 | 81 | PF00400 | 0.348 |
DEG_SCF_FBW7_2 | 202 | 209 | PF00400 | 0.479 |
DOC_CKS1_1 | 203 | 208 | PF01111 | 0.411 |
DOC_MAPK_gen_1 | 279 | 288 | PF00069 | 0.383 |
DOC_MAPK_gen_1 | 54 | 60 | PF00069 | 0.399 |
DOC_MAPK_HePTP_8 | 222 | 234 | PF00069 | 0.361 |
DOC_MAPK_MEF2A_6 | 225 | 234 | PF00069 | 0.364 |
DOC_MAPK_MEF2A_6 | 279 | 288 | PF00069 | 0.383 |
DOC_MAPK_RevD_3 | 176 | 191 | PF00069 | 0.436 |
DOC_PIKK_1 | 270 | 278 | PF02985 | 0.360 |
DOC_PP1_RVXF_1 | 168 | 175 | PF00149 | 0.436 |
DOC_PP4_FxxP_1 | 75 | 78 | PF00568 | 0.339 |
DOC_USP7_MATH_1 | 132 | 136 | PF00917 | 0.449 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.436 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.449 |
DOC_USP7_UBL2_3 | 12 | 16 | PF12436 | 0.486 |
DOC_USP7_UBL2_3 | 204 | 208 | PF12436 | 0.448 |
DOC_WW_Pin1_4 | 202 | 207 | PF00397 | 0.441 |
DOC_WW_Pin1_4 | 305 | 310 | PF00397 | 0.554 |
LIG_14-3-3_CanoR_1 | 184 | 188 | PF00244 | 0.531 |
LIG_14-3-3_CanoR_1 | 214 | 222 | PF00244 | 0.458 |
LIG_14-3-3_CanoR_1 | 231 | 235 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 63 | 70 | PF00244 | 0.522 |
LIG_Actin_WH2_2 | 129 | 145 | PF00022 | 0.454 |
LIG_Actin_WH2_2 | 38 | 56 | PF00022 | 0.325 |
LIG_APCC_ABBA_1 | 124 | 129 | PF00400 | 0.436 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.603 |
LIG_BRCT_BRCA1_1 | 185 | 189 | PF00533 | 0.436 |
LIG_BRCT_BRCA1_1 | 81 | 85 | PF00533 | 0.409 |
LIG_EVH1_1 | 77 | 81 | PF00568 | 0.271 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.436 |
LIG_FHA_1 | 214 | 220 | PF00498 | 0.391 |
LIG_LIR_Apic_2 | 72 | 78 | PF02991 | 0.355 |
LIG_LIR_Gen_1 | 261 | 268 | PF02991 | 0.378 |
LIG_LIR_Gen_1 | 280 | 288 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 197 | 203 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 205 | 210 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 261 | 265 | PF02991 | 0.384 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 280 | 286 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 289 | 295 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.435 |
LIG_MYND_3 | 86 | 90 | PF01753 | 0.517 |
LIG_Pex14_2 | 185 | 189 | PF04695 | 0.449 |
LIG_Pex14_2 | 32 | 36 | PF04695 | 0.350 |
LIG_PTB_Apo_2 | 217 | 224 | PF02174 | 0.347 |
LIG_PTB_Phospho_1 | 217 | 223 | PF10480 | 0.342 |
LIG_SH2_NCK_1 | 127 | 131 | PF00017 | 0.436 |
LIG_SH2_NCK_1 | 61 | 65 | PF00017 | 0.495 |
LIG_SH2_PTP2 | 57 | 60 | PF00017 | 0.408 |
LIG_SH2_SRC | 111 | 114 | PF00017 | 0.466 |
LIG_SH2_SRC | 127 | 130 | PF00017 | 0.436 |
LIG_SH2_SRC | 57 | 60 | PF00017 | 0.395 |
LIG_SH2_STAP1 | 127 | 131 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 223 | 227 | PF00017 | 0.355 |
LIG_SH2_STAT3 | 223 | 226 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 171 | 174 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 310 | 313 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.242 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.436 |
LIG_SH3_3 | 152 | 158 | PF00018 | 0.449 |
LIG_SH3_3 | 200 | 206 | PF00018 | 0.435 |
LIG_SH3_3 | 25 | 31 | PF00018 | 0.339 |
LIG_SH3_3 | 75 | 81 | PF00018 | 0.368 |
LIG_SUMO_SIM_anti_2 | 151 | 157 | PF11976 | 0.449 |
LIG_TRAF2_1 | 301 | 304 | PF00917 | 0.488 |
LIG_TRFH_1 | 75 | 79 | PF08558 | 0.343 |
LIG_UBA3_1 | 218 | 225 | PF00899 | 0.385 |
LIG_WW_2 | 78 | 81 | PF00397 | 0.271 |
MOD_CDK_SPxK_1 | 202 | 208 | PF00069 | 0.473 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.492 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.585 |
MOD_CK1_1 | 305 | 311 | PF00069 | 0.605 |
MOD_CK2_1 | 189 | 195 | PF00069 | 0.508 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.240 |
MOD_GlcNHglycan | 240 | 243 | PF01048 | 0.516 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.346 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.492 |
MOD_GSK3_1 | 305 | 312 | PF00069 | 0.686 |
MOD_N-GLC_1 | 104 | 109 | PF02516 | 0.236 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.455 |
MOD_NEK2_1 | 247 | 252 | PF00069 | 0.482 |
MOD_NEK2_1 | 302 | 307 | PF00069 | 0.468 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.328 |
MOD_NEK2_2 | 158 | 163 | PF00069 | 0.436 |
MOD_PIKK_1 | 213 | 219 | PF00454 | 0.395 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.436 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.414 |
MOD_PKA_2 | 230 | 236 | PF00069 | 0.463 |
MOD_PKA_2 | 62 | 68 | PF00069 | 0.504 |
MOD_Plk_1 | 158 | 164 | PF00069 | 0.503 |
MOD_Plk_1 | 247 | 253 | PF00069 | 0.426 |
MOD_Plk_1 | 260 | 266 | PF00069 | 0.305 |
MOD_Plk_1 | 286 | 292 | PF00069 | 0.351 |
MOD_Plk_1 | 302 | 308 | PF00069 | 0.493 |
MOD_Plk_4 | 302 | 308 | PF00069 | 0.507 |
MOD_Plk_4 | 36 | 42 | PF00069 | 0.298 |
MOD_Plk_4 | 81 | 87 | PF00069 | 0.442 |
MOD_ProDKin_1 | 202 | 208 | PF00069 | 0.455 |
MOD_ProDKin_1 | 305 | 311 | PF00069 | 0.564 |
TRG_DiLeu_BaEn_2 | 111 | 117 | PF01217 | 0.436 |
TRG_DiLeu_BaEn_3 | 151 | 157 | PF01217 | 0.492 |
TRG_DiLeu_BaLyEn_6 | 84 | 89 | PF01217 | 0.531 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.462 |
TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.334 |
TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.362 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.425 |
TRG_ER_diArg_1 | 189 | 191 | PF00400 | 0.436 |
TRG_NES_CRM1_1 | 115 | 129 | PF08389 | 0.436 |
TRG_Pf-PMV_PEXEL_1 | 191 | 195 | PF00026 | 0.447 |
TRG_Pf-PMV_PEXEL_1 | 266 | 270 | PF00026 | 0.419 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PEE1 | Leptomonas seymouri | 84% | 99% |
A0A0S4IWU2 | Bodo saltans | 71% | 100% |
A0A1X0NHW7 | Trypanosomatidae | 73% | 100% |
A0A3S7X925 | Leishmania donovani | 96% | 100% |
A4HMF0 | Leishmania braziliensis | 94% | 100% |
A4IB22 | Leishmania infantum | 96% | 100% |
C9ZNL8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 100% |
Q9GNH7 | Leishmania major | 96% | 100% |
V5B7T8 | Trypanosoma cruzi | 73% | 90% |